You are here

Iodine Deficiency May Reduce Pregnancy Chances, NIH Study Suggests

Low levels of the mineral are common among women

Women with moderate to severe iodine deficiency may take longer to achieve a pregnancy compared to women with normal iodine levels, according to a study by researchers at the National Institutes of Health. The study is the first to investigate the potential effects of mild to moderate iodine deficiency—common among women in the United States and the United Kingdom—on the ability to become pregnant. It appears in the latest edition of Human Reproduction.

Iodine is a mineral used by the body to regulate metabolism. It also helps regulate bone growth and brain development in children. It is found in seafood, iodized salt, dairy products, and some fruits and vegetables. Severe iodine deficiency has long been known to cause intellectual and developmental delays in infants.

“Our findings suggest that women who are thinking of becoming pregnant may need more iodine,” said James L. Mills, MD, who conducted the study along with colleagues at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development and the New York State Department of Health in Albany. “Iodine requirements increase during pregnancy, and the fetus depends on this mineral to make thyroid hormone and to ensure normal brain development.”

The researchers analyzed data collected from 501 U.S. couples who were planning pregnancy from 2005 to 2009. The couples were part of the Longitudinal Investigation of Fertility and the Environment (LIFE) study, which sought to examine the relationship between fertility, lifestyle, and environmental exposures. When the women enrolled in the study, they provided a urine sample from which their iodine levels were measured. Each woman was also given a digital, at-home pregnancy test.

Of the 467 women analyzed for the current study, iodine status was sufficient in 260 (55.7%), mildly deficient in 102 (21.8%), moderately deficient in 97 (20.8%) and severely deficient in eight (1.7%).

To estimate a couple’s chances of pregnancy during each menstrual cycle, the researchers used a statistical measure called the fecundability odds ratio (FOR). A FOR less than one suggests a longer time to pregnancy, while a FOR greater than one suggests a shorter time to pregnancy. The researchers found that women who had moderate-to-severe iodine deficiency had a 46% lower chance of becoming pregnant during each menstrual cycle, compared to women who had sufficient iodine concentrations. Women in the mildly deficient range had a smaller, statistically insignificant increase in the time it took to conceive.

Although the study population was not a representative sample of the U.S. population, the authors note that the percentage of women in the study having insufficient iodine (44.3%) is close to that seen in population-wide studies. For example, a previous study estimated that 30% of U.S. women of childbearing age had insufficient levels of iodine. The authors concluded that if their findings are confirmed, public health officials in countries where iodine deficiency is common may want to consider programs to increase iodine intake in women of child-bearing age.

Women who are concerned they may not be getting enough iodine may wish to consult their physicians before making dietary changes or taking supplements.

Source: National Institutes of Health; January 11, 2018.

More Headlines

Regimen showed significant improvement in overall survival in trial versus Sutent
Drug is first and only approved specific reversal agent for a novel oral anticoagulant
Test performed in the primary care setting may improve access to screening
Researchers found no association between clinical value and cost
Lenses automatically darken in bright light
Agent is now approved for the maintenance treatment of recurrent disease regardless of BRCA status
Agency aims to ensure women are properly informed of the risks
Approach would allow for drug testing in patients before clinical symptoms appear
Product would be the first lotion to combine halobetasol and tazarotene in one formulation